Point72 Asset Management L.P. Buys 117,421 Shares of Ardent Health Partners, LLC (NYSE:ARDT)

Point72 Asset Management L.P. lifted its holdings in shares of Ardent Health Partners, LLC (NYSE:ARDT - Free Report) by 7.9% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,609,720 shares of the company's stock after purchasing an additional 117,421 shares during the quarter. Point72 Asset Management L.P. owned about 1.13% of Ardent Health Partners worth $27,494,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in ARDT. US Bancorp DE purchased a new stake in shares of Ardent Health Partners during the 4th quarter valued at $31,000. R Squared Ltd purchased a new stake in shares of Ardent Health Partners during the 4th quarter valued at $37,000. New York State Common Retirement Fund purchased a new stake in shares of Ardent Health Partners during the 4th quarter valued at $48,000. Deutsche Bank AG grew its stake in shares of Ardent Health Partners by 1,251.9% during the 4th quarter. Deutsche Bank AG now owns 2,866 shares of the company's stock valued at $49,000 after buying an additional 2,654 shares during the period. Finally, JPMorgan Chase & Co. purchased a new stake in shares of Ardent Health Partners during the 3rd quarter valued at $154,000.

Ardent Health Partners Price Performance

Shares of ARDT traded down $0.05 during mid-day trading on Tuesday, reaching $15.10. The company had a trading volume of 114,845 shares, compared to its average volume of 395,705. Ardent Health Partners, LLC has a twelve month low of $11.31 and a twelve month high of $20.72. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78. The company's 50-day moving average is $13.20 and its 200-day moving average is $14.80. The company has a market capitalization of $2.16 billion and a P/E ratio of 9.26.

Ardent Health Partners (NYSE:ARDT - Get Free Report) last issued its earnings results on Tuesday, May 6th. The company reported $0.29 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.21 by $0.08. The company had revenue of $1.50 billion during the quarter, compared to analyst estimates of $1.50 billion. On average, equities analysts anticipate that Ardent Health Partners, LLC will post 1.23 EPS for the current year.

Analyst Ratings Changes

Several research analysts recently commented on the stock. Morgan Stanley cut their price target on shares of Ardent Health Partners from $23.50 to $22.00 and set an "overweight" rating on the stock in a report on Tuesday, January 21st. Guggenheim raised their target price on shares of Ardent Health Partners from $16.00 to $18.00 and gave the company a "buy" rating in a research note on Friday, May 9th. Royal Bank of Canada reaffirmed an "outperform" rating and set a $21.00 price target on shares of Ardent Health Partners in a research report on Thursday, May 15th. Mizuho lowered their price target on Ardent Health Partners from $19.00 to $18.00 and set an "outperform" rating for the company in a report on Wednesday, April 9th. Finally, Stephens restated an "overweight" rating and set a $21.00 price objective on shares of Ardent Health Partners in a research note on Tuesday. Two analysts have rated the stock with a hold rating, nine have issued a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, Ardent Health Partners presently has a consensus rating of "Buy" and an average target price of $20.67.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.